We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTL icon
3576
Unitil
UTL
$992M
$25K ﹤0.01%
422
+216
+105% +$11.7K
VSEC icon
3577
VSE Corp
VSEC
$6.48B
$25K ﹤0.01%
667
+10
+2% +$392
XAIR icon
3578
Beyond Air
XAIR
$6.14M
$25K ﹤0.01%
9
+4
+80% +$9.69K
LLAP
3579
DELISTED
Terran Orbital Corporation
LLAP
$25K ﹤0.01%
5,366
-1,704
-24% -$8.59K
PWSC
3580
DELISTED
PowerSchool Holdings, Inc.
PWSC
$25K ﹤0.01%
2,051
+267
+15% +$3.67K
ASTR
3581
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$25K ﹤0.01%
1,243
+325
+35% +$13.2K
LICY
3582
DELISTED
Li-Cycle Holdings Corp.
LICY
$25K ﹤0.01%
469
+328
+233% +$19.2K
GDNR
3583
DELISTED
Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
$25K ﹤0.01%
2,518
+538
+27% +$5.34K
DICE
3584
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$25K ﹤0.01%
1,611
-253
-14% -$4.35K
COLI
3585
DELISTED
Colicity Inc. Class A Common Stock
COLI
$25K ﹤0.01%
2,526
-707
-22% -$6.92K
LMACU
3586
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$25K ﹤0.01%
2,472
-103
-4% -$1.03K
RCHG
3587
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$25K ﹤0.01%
2,470
+1,020
+70% +$10.2K
ACCO icon
3588
Acco Brands
ACCO
$399M
$24K ﹤0.01%
3,601
+2,140
+146% +$15.6K
AQST icon
3589
Aquestive Therapeutics
AQST
$533M
$24K ﹤0.01%
38,139
+13,112
+52% +$17.4K
AROW icon
3590
Arrow Financial
AROW
$723M
$24K ﹤0.01%
809
+118
+17% +$3.55K
BBRE icon
3591
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.27B
$24K ﹤0.01%
+268
New +$25.9K
CDLX icon
3592
Cardlytics
CDLX
$25.1M
$24K ﹤0.01%
106
+21
+25% +$7.03K
CRH icon
3593
CRH
CRH
$65B
$24K ﹤0.01%
680
-8,480
-93% -$330K
CTLP
3594
DELISTED
Cantaloupe
CTLP
$24K ﹤0.01%
4,226
+2,484
+143% +$13.2K
CZNC icon
3595
Citizens & Northern Corp
CZNC
$466M
$24K ﹤0.01%
987
-980
-50% -$23.7K
DBE icon
3596
Invesco DB Energy Fund
DBE
$90.5M
$24K ﹤0.01%
900
-362
-29% -$9.61K
EWQ icon
3597
iShares MSCI France ETF
EWQ
$332M
$24K ﹤0.01%
787
+478
+155% +$15.7K
FEMY icon
3598
Femasys
FEMY
$6.91M
$24K ﹤0.01%
503
+441
+711% +$14.9K
FTAI icon
3599
FTAI Aviation
FTAI
$22.2B
$24K ﹤0.01%
1,456
-874
-38% -$15.5K
GRFS
3600
Grifois
GRFS
$5.4B
$24K ﹤0.01%
2,057
-10,804
-84% -$129K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.